SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Novel and existing flexible survival methods for network meta-analyses
9 references·0 citing·34 second hop
Novel and existing flexible survival methods for network meta-analyses (2022)Novel and existing flexible survival meth…Multilevel Network Meta-Regression for Population-Adjusted Treatment Comparisons (2020)Multilevel Network Meta-Regre…Estimating Lifetime Benefits Associated with Immuno-Oncology Therapies: Challenges and Approaches for Overall Survival Extrapolations (2019)Estimating Lifetime Benefits …Network Meta‐Analysis for Decision Making (2018)Network Meta‐Analysis for Dec…Bayesian one‐step IPD network meta‐analysis of time‐to‐event data using Royston‐Parmar models (2017)Bayesian one‐step IPD network…Quantitative summaries of treatment effect estimates obtained with network meta-analysis of survival curves to inform decision-making (2013)Quantitative summaries of tre…Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves (2012)Enhanced secondary analysis o…NICE DSU Technical Support Document 18 (2011)NICE DSU Technical Support Do…Network meta-analysis of survival data with fractional polynomials (2011)Network meta-analysis of surv…Network meta‐analysis of parametric survival curves (2010)Network meta‐analysis of para…Combination of direct and indirect evidence in mixed treatment comparisons (2004)Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial (2010)Evidence Synthesis for Decision Making 2 (2012)Multivariate network meta‐analysis of survival function parameters (2020)Uptake of methodological advances for synthesis of continuous and time-to-event outcomes would maximize use of the evidence base (2020)Challenges of modelling approaches for network meta-analysis of time-to-event outcomes in the presence of non-proportional hazards to aid decision making: Application to a melanoma network (2022)Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints (1998)CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010)Choosing effect measures and computing estimates of effect (2019)IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves (2021)Network meta‐analysis for indirect treatment comparisons (2002)Assessing Evidence Inconsistency in Mixed Treatment Comparisons (2006)Combining individual patient data and aggregate data in mixed treatment comparison meta‐analysis: Individual patient data may be beneficial if only for a subset of trials (2012)A process for assessing the feasibility of a network meta-analysis: a case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer (2014)Twenty years of network meta‐analysis: Continuing controversies and recent developments (2024)The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001)Incorporating Lag Time to Benefit Into Prevention Decisions for Older Adults (2013)Measuring inconsistency in meta-analyses (2003)A Re-Evaluation of Random-Effects Meta-Analysis (2008)Checking consistency in mixed treatment comparison meta‐analysis (2010)Individual patient data network meta-analysis using either restricted mean survival time difference or hazard ratios: is there a difference? A case study on locoregionally advanced nasopharyngeal carcinomas (2019)Progress and challenges of network meta‐analysis (2021)Decision Modelling For Health Economic Evaluation (2006)Survival Analysis for Economic Evaluations Alongside Clinical Trials—Extrapolation with Patient-Level Data (2013)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Evaluating Partitioned Survival and Markov Decision-Analytic Modeling Approaches for Use in Cost-Effectiveness Analysis: Estimating and Comparing Survival Outcomes (2019)Current challenges for assessing the long-term clinical benefit of cancer immunotherapy: a multi-stakeholder perspective (2020)The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials (1997)Assessing the performance of population adjustment methods for anchored indirect comparisons: A simulation study (2020)Theory and practice of Bayesian and frequentist frameworks for network meta-analysis (2022)A Bayesian Mixed-Treatment Comparison Meta-analysis of Treatments for Alcohol Dependence and Implications for Planning Future Trials (2014)BUGSnet: an R package to facilitate the conduct and reporting of Bayesian network Meta-analyses (2019)Undertaking network meta‐analyses (2019)Employment Instability and Fertility in Europe: A Meta-Analysis (2021)
this work references cited by second hop

References

  • 2012Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves2,553 cited
  • 2018Network Meta‐Analysis for Decision Making340 cited
  • 2020Multilevel Network Meta-Regression for Population-Adjusted Treatment Comparisons181 cited
  • 2011Network meta-analysis of survival data with fractional polynomials166 cited
  • 2010Network meta‐analysis of parametric survival curves117 cited
  • 2019Estimating Lifetime Benefits Associated with Immuno-Oncology Therapies: Challenges and Approaches for Overall Survival Extrapolations94 cited
  • 2011NICE DSU Technical Support Document 1873 cited
  • 2013Quantitative summaries of treatment effect estimates obtained with network meta-analysis of survival curves to inform decision-making50 cited
  • 2017Bayesian one‐step IPD network meta‐analysis of time‐to‐event data using Royston‐Parmar models42 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work